Trials / Conditions / Persistent Pulmonary Hypertension of the Newborn

Persistent Pulmonary Hypertension of the Newborn

16 registered clinical trials studyying Persistent Pulmonary Hypertension of the Newborn — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Close Loop Smart Weaning for INO With PPHN NCT06832163	Children's Hospital of Fudan University	N/A
Completed	The Effect Of Nebulizied Nitroglycerin As An Adjuvant Therapy For Persistent Pulmonary Hypertension Of Newborn NCT05741229	Alexandria University	N/A
Completed	Efficacy of Milrinone With Sildenafil in Persistent Pulmonary Hypertension in Children NCT06562036	Muhammad Aamir Latif	N/A
Active Not Recruiting	Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pul NCT04938167	University of California, Davis	N/A
Completed	NEURodevelopmental Outcome After Persistent Pulmonary Hypertension Of the Newborn NCT04841070	University Hospital, Toulouse	N/A
Unknown	Population Pharmacokinetics and Dosage Individualization of Oral Pulmonary Vasodilators in PPHN NCT04379180	Shandong University	—
Completed	Nebulized MgSO4 in Persistent Pulmonary Hypertension of Newborn NCT04328636	Sohag University	Phase 1 / Phase 2
Completed	Milrinone in Congenital Diaphragmatic Hernia NCT02951130	NICHD Neonatal Research Network	Phase 2
Completed	Markers of Inflammation and Lung Recovery in ECMO Patients for PPHN NCT02940327	University of Leicester	—
Terminated	Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn NCT02261883	United Therapeutics	Phase 2
Unknown	Plethismographic Perfusion Index in Neonates NCT02380040	Shaare Zedek Medical Center	—
Completed	Pharmacokinetics of Sildenafil in Premature Infants NCT01670136	University of North Carolina, Chapel Hill	Phase 1
Withdrawn	IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn NCT01360671	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 2
Terminated	Persistent Pulmonary Hypertension of the Newborn NCT01389856	Actelion	Phase 3
Terminated	Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension NCT01069861	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 2
Recruiting	PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn NCT00710177	Medical College of Wisconsin	—